Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 143 entries
Sorted by: Best Match Show Resources per page
Tapentadol extended release in the management of peripheral diabetic neuropathic pain.

Therapeutics and clinical risk management

Vadivelu N, Kai A, Maslin B, Kodumudi G, Legler A, Berger JM.
PMID: 25609974
Ther Clin Risk Manag. 2015 Jan 14;11:95-105. doi: 10.2147/TCRM.S32193. eCollection 2015.

Tapentadol, a μ-opioid agonist and norepinephrine reuptake inhibitor, has been found to be an effective medication for a wide variety of chronic pain conditions, including back pain, cancer-related pain, and arthritic pain. It has also been found to have...

Cite
Vadivelu N, Kai A, Maslin B, et al. Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Ther Clin Risk Manag. 2015;11:95-105doi: 10.2147/TCRM.S32193.
Vadivelu, N., Kai, A., Maslin, B., Kodumudi, G., Legler, A., & Berger, J. M. (2015). Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Therapeutics and clinical risk management, 1195-105. https://doi.org/10.2147/TCRM.S32193
Vadivelu, Nalini, et al. "Tapentadol extended release in the management of peripheral diabetic neuropathic pain." Therapeutics and clinical risk management vol. 11 (2015): 95-105. doi: https://doi.org/10.2147/TCRM.S32193
Vadivelu N, Kai A, Maslin B, Kodumudi G, Legler A, Berger JM. Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Ther Clin Risk Manag. 2015 Jan 14;11:95-105. doi: 10.2147/TCRM.S32193. eCollection 2015. PMID: 25609974; PMCID: PMC4298300.
Copy Download .nbib Format: NLM
Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?.

The Korean journal of pain

Chang EJ, Choi EJ, Kim KH.
PMID: 27413479
Korean J Pain. 2016 Jul;29(3):153-7. doi: 10.3344/kjp.2016.29.3.153. Epub 2016 Jul 01.

Tapentadol is a novel oral analgesic with a dual mode of action as an agonist of the µ-opioid receptor (MOR), and as a norepinephrine reuptake inhibitor (NRI) all in a single molecule. Immediate release (IR) tapentadol shows its analgesic...

Cite
Chang EJ, Choi EJ, Kim KH. Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?. Korean J Pain. 2016;29(3):153-7doi: 10.3344/kjp.2016.29.3.153.
Chang, E. J., Choi, E. J., & Kim, K. H. (2016). Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?. The Korean journal of pain, 29(3), 153-7. https://doi.org/10.3344/kjp.2016.29.3.153
Chang, Eun Jung, et al. "Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?." The Korean journal of pain vol. 29,3 (2016): 153-7. doi: https://doi.org/10.3344/kjp.2016.29.3.153
Chang EJ, Choi EJ, Kim KH. Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?. Korean J Pain. 2016 Jul;29(3):153-7. doi: 10.3344/kjp.2016.29.3.153. Epub 2016 Jul 01. PMID: 27413479; PMCID: PMC4942642.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Tomillero A, Moral MA.
PMID: 20508873
Methods Find Exp Clin Pharmacol. 2010 May;32(4):247-88. doi: 10.1358/mf.2010.32.4.1507200.

O(6)-Benzylguanine; (-)-Gossypol; Abatacept, AC-2592, Adalimumab, AIDSVAX gp120 B/E, Alemtuzumab, Aliskiren fumarate, ALVAC E120TMG, Ambrisentan, Amlodipine, Anakinra, Aripiprazole, Armodafinil, Atomoxetine hydrochloride, Avotermin; Bevacizumab, BIBW-2992, Bortezomib, Bosentan, Botulinum toxin type B; Canakinumab, CAT-354, Ciclesonide, CMV gB vaccine, Corifollitropin alfa, Daptomycin, Darbepoetin...

Cite
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2010;32(4):247-88doi: 10.1358/mf.2010.32.4.1507200.
Tomillero, A., & Moral, M. A. (2010). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 32(4), 247-88. https://doi.org/10.1358/mf.2010.32.4.1507200
Tomillero, A, and Moral, M A. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 32,4 (2010): 247-88. doi: https://doi.org/10.1358/mf.2010.32.4.1507200
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2010 May;32(4):247-88. doi: 10.1358/mf.2010.32.4.1507200. PMID: 20508873.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Tomillero A, Moral MA.
PMID: 19967103
Methods Find Exp Clin Pharmacol. 2009 Oct;31(8):541-57.

[Methoxy-11c]PD-153035; Afamelanotide, Agalsidase beta, Alemtuzumab, Alkaline phosphatase, Amlodipine, Anecortave acetate, Apixaban, Aripiprazole, Atomoxetine hydrochloride; Bevacizumab, Bortezomib, Bosentan, Botulinum toxin type B, Brimonidine tartrate/timolol maleate, Brivudine; Canakinumab, Cetuximab, Chlorotoxin, Cinaciguat; Dapagliflozin, Decitabine, Duloxetine hydrochloride; Elagolix sodium, Eplerenone, Eritoran tetrasodium, Escitalopram...

Cite
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2009;31(8):541-57
Tomillero, A., & Moral, M. A. (2009). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 31(8), 541-57.
Tomillero, A, and Moral, M A. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 31,8 (2009): 541-57.
Tomillero A, Moral MA. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2009 Oct;31(8):541-57. PMID: 19967103.
Copy Download .nbib Format: NLM
Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome.

Pain research and treatment

Paladini A, Varrassi G, Bentivegna G, Carletti S, Piroli A, Coaccioli S.
PMID: 28875041
Pain Res Treat. 2017;2017:1486010. doi: 10.1155/2017/1486010. Epub 2017 Aug 10.

INTRODUCTION: This observational study was designed to evaluate the efficacy of ultramicronized palmitoylethanolamide (um-PEA) (Normast®) administration, as add-on therapy for chronic pain, in the management of pain-resistant patients affected by failed back surgery syndrome.METHODS: A total of 35 patients...

Cite
Paladini A, Varrassi G, Bentivegna G, et al. Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome. Pain Res Treat. 2017;2017:1486010doi: 10.1155/2017/1486010.
Paladini, A., Varrassi, G., Bentivegna, G., Carletti, S., Piroli, A., & Coaccioli, S. (2017). Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome. Pain research and treatment, 20171486010. https://doi.org/10.1155/2017/1486010
Paladini, Antonella, et al. "Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome." Pain research and treatment vol. 2017 (2017): 1486010. doi: https://doi.org/10.1155/2017/1486010
Paladini A, Varrassi G, Bentivegna G, Carletti S, Piroli A, Coaccioli S. Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome. Pain Res Treat. 2017;2017:1486010. doi: 10.1155/2017/1486010. Epub 2017 Aug 10. PMID: 28875041; PMCID: PMC5569747.
Copy Download .nbib Format: NLM
Efficacy and tolerability of tapentadol prolonged release in the elderly and fragile patient: an observational study.

European review for medical and pharmacological sciences

Zampi M.
PMID: 32633417
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6477.

The article "Efficacy and tolerability of tapentadol prolonged release in the elderly and fragile patient: an observational study, M. Zampi published in Eur Rev Med Pharmacol Sci 2019; 23 (4 Suppl): 45-50. DOI: 10.26355/eurrev_201911_19371. PMID: 31755084" has been withdrawn...

Cite
Zampi M. Efficacy and tolerability of tapentadol prolonged release in the elderly and fragile patient: an observational study. Eur Rev Med Pharmacol Sci. 2020;24(12):6477
Zampi, M. (2020). Efficacy and tolerability of tapentadol prolonged release in the elderly and fragile patient: an observational study. European review for medical and pharmacological sciences, 24(12), 6477.
Zampi, M. "Efficacy and tolerability of tapentadol prolonged release in the elderly and fragile patient: an observational study." European review for medical and pharmacological sciences vol. 24,12 (2020): 6477.
Zampi M. Efficacy and tolerability of tapentadol prolonged release in the elderly and fragile patient: an observational study. Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6477. PMID: 32633417.
Copy Download .nbib Format: NLM
Fast and Localized Temperature Measurements During Simulated Earthquakes in Carbonate Rocks.

Geophysical research letters

Aretusini S, Núñez-Cascajero A, Spagnuolo E, Tapetado A, Vázquez C, Di Toro G.
PMID: 34219843
Geophys Res Lett. 2021 May 16;48(9):e2020GL091856. doi: 10.1029/2020GL091856. Epub 2021 May 10.

The understanding of earthquake physics is hindered by the poor knowledge of fault strength and temperature evolution during seismic slip. Experiments reproducing seismic velocity (∼1 m/s) allow us to measure both the evolution of fault strength and the associated...

Cite
Aretusini S, Núñez-Cascajero A, Spagnuolo E, et al. Fast and Localized Temperature Measurements During Simulated Earthquakes in Carbonate Rocks. Geophys Res Lett. 2021;48(9):e2020GL091856doi: 10.1029/2020GL091856.
Aretusini, S., Núñez-Cascajero, A., Spagnuolo, E., Tapetado, A., Vázquez, C., & Di Toro, G. (2021). Fast and Localized Temperature Measurements During Simulated Earthquakes in Carbonate Rocks. Geophysical research letters, 48(9), e2020GL091856. https://doi.org/10.1029/2020GL091856
Aretusini, Stefano, et al. "Fast and Localized Temperature Measurements During Simulated Earthquakes in Carbonate Rocks." Geophysical research letters vol. 48,9 (2021): e2020GL091856. doi: https://doi.org/10.1029/2020GL091856
Aretusini S, Núñez-Cascajero A, Spagnuolo E, Tapetado A, Vázquez C, Di Toro G. Fast and Localized Temperature Measurements During Simulated Earthquakes in Carbonate Rocks. Geophys Res Lett. 2021 May 16;48(9):e2020GL091856. doi: 10.1029/2020GL091856. Epub 2021 May 10. PMID: 34219843; PMCID: PMC8243964.
Copy Download .nbib Format: NLM
Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature.

Clinical case reports

Haji K, Muthu S, Banakh I, Tiruvoipati R.
PMID: 33768845
Clin Case Rep. 2021 Feb 04;9(3):1362-1366. doi: 10.1002/ccr3.3772. eCollection 2021 Mar.

A combination of pregabalin and tapentadol may be associated with prolonged encephalopathy.

Cite
Haji K, Muthu S, Banakh I, et al. Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature. Clin Case Rep. 2021;9(3):1362-1366doi: 10.1002/ccr3.3772.
Haji, K., Muthu, S., Banakh, I., & Tiruvoipati, R. (2021). Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature. Clinical case reports, 9(3), 1362-1366. https://doi.org/10.1002/ccr3.3772
Haji, Kavi, et al. "Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature." Clinical case reports vol. 9,3 (2021): 1362-1366. doi: https://doi.org/10.1002/ccr3.3772
Haji K, Muthu S, Banakh I, Tiruvoipati R. Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature. Clin Case Rep. 2021 Feb 04;9(3):1362-1366. doi: 10.1002/ccr3.3772. eCollection 2021 Mar. PMID: 33768845; PMCID: PMC7981720.
Copy Download .nbib Format: NLM
Importance of blinding and expectations in opioid-induced constipation: evidence from a randomized controlled trial.

Scandinavian journal of pain

Sieg M, Mark EB, Drewes AM, Vase L.
PMID: 34710314
Scand J Pain. 2021 Oct 28; doi: 10.1515/sjpain-2021-0115. Epub 2021 Oct 28.

OBJECTIVES: Previous studies have found little association between objective measures and the subjective experience of opioid-induced constipation. The subjective experience of opioid-induced constipation may be influenced by treatment expectations. While most trials control for treatment expectations through blinding, success...

Cite
Sieg M, Mark EB, Drewes AM, et al. Importance of blinding and expectations in opioid-induced constipation: evidence from a randomized controlled trial. Scand J Pain. 2021;doi: 10.1515/sjpain-2021-0115.
Sieg, M., Mark, E. B., Drewes, A. M., & Vase, L. (2021). Importance of blinding and expectations in opioid-induced constipation: evidence from a randomized controlled trial. Scandinavian journal of pain, . https://doi.org/10.1515/sjpain-2021-0115
Sieg, Mette, et al. "Importance of blinding and expectations in opioid-induced constipation: evidence from a randomized controlled trial." Scandinavian journal of pain vol. (2021). doi: https://doi.org/10.1515/sjpain-2021-0115
Sieg M, Mark EB, Drewes AM, Vase L. Importance of blinding and expectations in opioid-induced constipation: evidence from a randomized controlled trial. Scand J Pain. 2021 Oct 28; doi: 10.1515/sjpain-2021-0115. Epub 2021 Oct 28. PMID: 34710314.
Copy Download .nbib Format: NLM
Combining Transcranial Direct Current Stimulation and Transcutaneous Electrical Nerve Stimulation to Relieve Persistent Pain in a Patient Suffering from Complex Regional Pain Syndrome: A Case Report.

Journal of pain research

Houde F, Harvey MP, Tremblay Labrecque PF, Lamarche F, Lefebvre A, Leonard G.
PMID: 32184651
J Pain Res. 2020 Mar 02;13:467-473. doi: 10.2147/JPR.S226616. eCollection 2020.

PURPOSE: Complex regional pain syndrome (CRPS) is a rare neuropathic pain condition characterized by sensory, motor and autonomic alterations. Previous investigations have shown that transcranial direct current stimulation (tDCS) and transcutaneous electrical nerve stimulation (TENS) can alleviate pain in...

Cite
Houde F, Harvey MP, Tremblay Labrecque PF, et al. Combining Transcranial Direct Current Stimulation and Transcutaneous Electrical Nerve Stimulation to Relieve Persistent Pain in a Patient Suffering from Complex Regional Pain Syndrome: A Case Report. J Pain Res. 2020;13:467-473doi: 10.2147/JPR.S226616.
Houde, F., Harvey, M. P., Tremblay Labrecque, P. F., Lamarche, F., Lefebvre, A., & Leonard, G. (2020). Combining Transcranial Direct Current Stimulation and Transcutaneous Electrical Nerve Stimulation to Relieve Persistent Pain in a Patient Suffering from Complex Regional Pain Syndrome: A Case Report. Journal of pain research, 13467-473. https://doi.org/10.2147/JPR.S226616
Houde, Francis, et al. "Combining Transcranial Direct Current Stimulation and Transcutaneous Electrical Nerve Stimulation to Relieve Persistent Pain in a Patient Suffering from Complex Regional Pain Syndrome: A Case Report." Journal of pain research vol. 13 (2020): 467-473. doi: https://doi.org/10.2147/JPR.S226616
Houde F, Harvey MP, Tremblay Labrecque PF, Lamarche F, Lefebvre A, Leonard G. Combining Transcranial Direct Current Stimulation and Transcutaneous Electrical Nerve Stimulation to Relieve Persistent Pain in a Patient Suffering from Complex Regional Pain Syndrome: A Case Report. J Pain Res. 2020 Mar 02;13:467-473. doi: 10.2147/JPR.S226616. eCollection 2020. PMID: 32184651; PMCID: PMC7060070.
Copy Download .nbib Format: NLM
Tapentadol: an overview of the safety profile.

Journal of pain research

Polati E, Canonico PL, Schweiger V, Collino M.
PMID: 31190968
J Pain Res. 2019 May 16;12:1569-1576. doi: 10.2147/JPR.S190154. eCollection 2019.

Long-term opioid therapy may be associated with analgesic efficacy and also predictable adverse events, including cardiovascular and pulmonary events, gastrointestinal disorders, endocrinological harms, psychological problems, impairment of driving ability, and risk of abuse. These effects of opioids are mostly...

Cite
Polati E, Canonico PL, Schweiger V, et al. Tapentadol: an overview of the safety profile. J Pain Res. 2019;12:1569-1576doi: 10.2147/JPR.S190154.
Polati, E., Canonico, P. L., Schweiger, V., & Collino, M. (2019). Tapentadol: an overview of the safety profile. Journal of pain research, 121569-1576. https://doi.org/10.2147/JPR.S190154
Polati, Enrico, et al. "Tapentadol: an overview of the safety profile." Journal of pain research vol. 12 (2019): 1569-1576. doi: https://doi.org/10.2147/JPR.S190154
Polati E, Canonico PL, Schweiger V, Collino M. Tapentadol: an overview of the safety profile. J Pain Res. 2019 May 16;12:1569-1576. doi: 10.2147/JPR.S190154. eCollection 2019. PMID: 31190968; PMCID: PMC6529613.
Copy Download .nbib Format: NLM
Tapentadol: a new option for the treatment of cancer and noncancer pains.

Journal of pain research

Dickenson AH, Kress HG.
PMID: 31190961
J Pain Res. 2019 May 16;12:1509-1511. doi: 10.2147/JPR.S190171. eCollection 2019.

No abstract available.

Cite
Dickenson AH, Kress HG. Tapentadol: a new option for the treatment of cancer and noncancer pains. J Pain Res. 2019;12:1509-1511doi: 10.2147/JPR.S190171.
Dickenson, A. H., & Kress, H. G. (2019). Tapentadol: a new option for the treatment of cancer and noncancer pains. Journal of pain research, 121509-1511. https://doi.org/10.2147/JPR.S190171
Dickenson, Anthony H, and Kress, Hans G. "Tapentadol: a new option for the treatment of cancer and noncancer pains." Journal of pain research vol. 12 (2019): 1509-1511. doi: https://doi.org/10.2147/JPR.S190171
Dickenson AH, Kress HG. Tapentadol: a new option for the treatment of cancer and noncancer pains. J Pain Res. 2019 May 16;12:1509-1511. doi: 10.2147/JPR.S190171. eCollection 2019. PMID: 31190961; PMCID: PMC6526922.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 143 entries